Maxim downgraded BrainStorm (BCLI) to Hold from Buy.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCLI:
- Brainstorm Cell Therapeutics Faces Nasdaq Delisting Notice
- BrainStorm announces Nasdaq delisting and transition to OTCQB
- Brainstorm Cell Therapeutics Approves Stock Plan Amendments
- BrainStorm files to sell 2.76M shares of common stock for holders
- Promising Survival Data and Regulatory Progress Bolster Buy Rating for Brainstorm Cell Therapeutics